Companies

St. Jude Medical’s large European clinical trial of its Nanostim pacemaker is hoped to add to the building evidence supporting strong safety profile and performance of the world’s first leadless pacemaker.

The U.S. FDA has said Biotronik can move onto phase C of its ProMRI study which will investigate the company’s MRI-compatible technology in its implantable cardioverter-defibrillator (ICD) devices.

Spinal technologies company K2M, Inc., put the wheels in motion for an IPO back in January. Now the company has filed the papers which could see it raise $100 million in order to fund debt repayments and future investment to build on an already healthily growing revenue stream.

Italian Cardiovascular device company Sorin Group has announced the purchase of the Oscor Inc. lead business, including a lead manufacturing facility in the Dominican Republic for an aggregate value of approximately $20 million (Eur15.4 million).

Boston Scientific Corporation has announced CE Mark approval and European market launch of the INGEVITY™ family of magnetic resonance imaging (MRI) compatible pacing leads.

After all the hoo haa of the last few years pertaining to the damaging outcome of some metal-on-metal hip implants, US patient advocacy group The Drugs Watchdog has now issued a press release strongly suggesting DePuy Pinnacle all metal hip implantees contact it to discuss their options, the most likely suggestion being to demand an MRI.

Boston Scientific Corporation has received CE Mark approval for the REBEL™ Platinum Chromium Coronary Stent System, the company’s latest generation … continue reading “CE Mark for Boston Scientific’s REBEL™ Platinum Chromium Coronary Stent”

Smith & Nephew has used the AAOS annual meeting at which to announce the launch of the JOURNEY™ II Cruciate Retaining knee replacement which it says will address about half of all knee replacement cases.

Smith & Nephew says its newly launched DYONICS PLAN system allows surgeons to visualize, assess and generate a comprehensive surgical report for each patient’s unique Femoroacetabular impingement surgery before that patient ever enters the operating room.

Stryker Corporation tells us it has completed its previously announced all-cash acquisition of Pivot Medical Inc., a move the Kalamazoo device company will hope enhances its position in the orthopaedic sports medicine and arthroscopy specialties.

Smith & Nephew which has signed an agreement with OrthoSensor that will pair the company’s VERASENSE Sensor Assisted Surgery Technology for soft tissue balancing with Smith & Nephew’s JOURNEY™ II and LEGION™ Total Knee Systems.

Quite a time for AngioDynamics. First the company gets news that another iteration of its successful BioFlo platform has gained FDA’s nod. Then, its distribution partner Medcomp gets the FDA’s knock-back over its 510(k) submission for the Celerity tip location system, leading AngioDynamics to take over the regulatory reigns there too.

An implantable drug delivery pump forms the basis of a new company, Medallion Therapeutics, Inc., which has sprung from the Alfred Mann Foundation (AMF) for Scientific Research.

Invuity’s clever delivery of lighting to even the most awkward surgical site is clearly winning surgeon fans, the company’s sales having doubled last year. Now a new successful funding round will enable it to accelerate its activities.

Frequent visitor to our pages, cardiovascular device company Biotronik has announced the first implantations of the Sentus ProMRI® lead.

Cook Medical has updated us with news that the first ten patients in its VIVO venous stent study have been treated with the Zilver Vena stent.